Therapy of Feto-Placental Insufficiency: I. International Symposium Parma, May 19th and 20th 1973

Front Matter....Pages I-XV
Plasma Oestriol in Obstetric Disease....Pages 1-9
Validity of Cardiotocography in the Control of Feto-Placental Insufficiency. Preliminary Results....Pages 10-17
The Diagnosis of “Small for Dates” Babies by the Cytological Examination of the Amniotic Fluid....Pages 18-20
The Value of the Atropine Test in Therapeutic Orientation during Feto-Placental Insufficiency....Pages 21-23
Assessment of the Value of Hormonal Assays and Ultrasonic Measurements in the Management of Placental Insufficiency....Pages 24-29
Human Placental Lactogen as an Index of Placental Function: Plasma Measurements in Normal and Pathological Pregnancies....Pages 30-34
Human Choriogonadotropin, Choriosomatomammotrophin and Fetal Nutrition....Pages 35-36
The Clinical Value of the Placenta Lactogen in the Monitoring of Feto-Placental Disfunction....Pages 37-40
Amniotic Fluid Analysis in Placental Insufficiency....Pages 41-47
Thermostable Alkaline Phosphatases in Feto-Placental Insufficiency....Pages 48-52
The Insulin Tolerance Test (I.T.T.) as a Basis for the Therapy of Placental Insufficiency....Pages 53-54
Radioimmunologic Determination of Plasma Estriol in Pregnancy with a Specific Antiserum to Estriol....Pages 55-59
Some Parameters of Feto-Placental Insufficiency....Pages 60-66
Urinary Estriol as a Therapeutic Guide of Feto-Placental Failure in the Vasculo-Renal Hypertensive Syndrome of Pregnancy....Pages 67-67
Diagnosis of Fetal Maturity by Biochemical and Cytological Studies....Pages 68-71
Radioimmunological Determination of Human Placental Lactogen (HPL), Cystynyloaminopeptidase (CAP) and Daily Excretion of Urinary Oestriol in the Diagnosis of Chronic Placental Insufficiency....Pages 72-74
Oestriol as Guide in the Treatment of Feto-Placental Insufficiency: Possibilities and Limits....Pages 75-77
The Comparative Studies about the Estriol and HPL Production Rate in the Risk-Pregnancies....Pages 78-82
The Pathology of Feto-Placental Insufficiency in Hypertensive Pregnancy....Pages 83-97
Search for a Disturbance of Coagulation during Pregnancy in Cases of Intra-Uterine Growth Retardation....Pages 98-103
Pathways of Glucose Metabolism in Human Placentae....Pages 104-105
Experimental Investigations about Blood Flow and Oxygen-Consumption in Normal Pregnancy and Placental Dysfunction....Pages 106-108
The Role of the Fetal Circulation in Placental Insufficiency....Pages 109-110
Effect of an Adrenergic ß-Mimetic Compound (Ritodrine Hydrochloride) on the Feto-Placental Unit in Chronic Fetal Distress....Pages 111-125
The Effect of a Beta-Mimetic (Ritodrine) on the Uterine Circulation during Normal and Pathological (Chronic Fetal Distress) Pregnancies. Therapeutic Implications....Pages 126-128
The Effects of Beta-Mimetic (Ritodrine) during Pregnancy on Carbohydrate Metabolism and Hepatic Function of the Newborn Infant....Pages 129-131
The Influence of a Beta-Mimetic on Placental Function-Tests....Pages 132-134
Adrenergic ß-Mimetic-Compounds and Utero-Placental Blood Supply in Risk Pregnancies....Pages 135-136
Early Trials in the Treatment of Placental Insufficiency with Ritodrine....Pages 137-141
The Effect of Ritodrine on Infant Weight....Pages 142-149
Oestrogen Excretion in a Group of 90 Pregnant Women Treated with Ritodrine....Pages 150-153
The Influence of Some Preparations on the Feto-Placental Insufficiency....Pages 154-155
Effects of a Beta-Adrenergic Agent on the Angiographically Visualized Uteroplacental Circulation in the Rhesus Monkey....Pages 156-158
Orciprenaline in the Treatment of Premature Labour....Pages 159-160
Betamimetic Drugs and the Feto-Placental Function....Pages 161-163
Betamimetics and Placental Insufficiency Due to Uterine Hypoplasia....Pages 164-167
Placental Function and Xanthinol-Nicotinate....Pages 168-178
The Therapy of EPH Gestosis with Xantinol-Nicotinat: Short-Term Reactions of Blood Coagulation, Fibrinolysis and Human Placental Lactogen....Pages 179-182
Ultrasound Study of the Effect of Hydergin on Feto-Placental Insufficiency....Pages 183-192
Therapy of Feto-Placental Insufficiency with Xantinol-Nicothinate, Glucose and Insulin....Pages 193-199
Maternal Excretion of Oestriol before and during Treatment of Placental Insufficiency with Xantinol-Nicotinate....Pages 200-202
Xanthinol Nicotinate in the Treatment of EPH Gestosis....Pages 203-206
The Treatment of EPH-Gestosis with Xantinol-Nicotinat-Alterations of HPL and Coagulation-Physiological Alterations over Long Periods....Pages 207-210
The Behaviour of Serum Electrolytes, Serum Protein, and of the Substances to be Eliminated in the Case of Gestosis Treated with Xantinol-Nicotinat and Heparin....Pages 211-214
Long Term Heparin Therapy for Placental Insufficiency....Pages 215-220
Therapy of Feto-Placental Insufficiency during Pregnancy the Effects of Drugs on Placental Function....Pages 221-231
Intra-Uterine Growth of Newborn Infants of Parma....Pages 232-235
Maternal Hypertonic Dextrose Infusion in a Patient with Idiopathic Recurrent Placental Insufficiency and Low Urinary Oestrogens....Pages 236-238
Improvements in Uterine-Placental Blood-Flow by Long-Term Treatment of EPH-Gestosis with Anti-Hypertensive Drugs....Pages 239-244
Vasoactive or Phosphorilated Glycide Therapy in Placental Insufficiency....Pages 245-245
Effects of Synthetic Luteinizing Hormone-Releasing Hormone (LH-RH) on Serum Gonadotrophin, Prolactin and Chorionic Somatomammotrophin (HCS) during the Last Trimester of Pregnancy....Pages 246-249
Trial of Treatment of Chronic Fetal Distress by Naftidrofuryl....Pages 250-250
Chronic Fetal Distress. Research on Placental Blood Flow and Therapy....Pages 251-256
The Effect of Abdominal Decompression on the Newborn....Pages 257-259
The Use of Intermittent Abdominal Decompression and Oestriol Monitoring in the Treatment of Feto-Placental Insufficiency....Pages 260-264
Intra-Amniotic Amino-Acid Injections....Pages 265-291
The Effects of Maternal Infusions of L-Amino Acids as a Treatment of Chronic Fetal-Placental Insufficiency....Pages 292-293
Plasma Amino-Acids in “Small for Date” Newborn Infants....Pages 294-295
Treatment of Severe Feto-Placental Insufficiency by Means of Intraamniotic Injection of Amino-Acids....Pages 296-301
Fetal and Maternal Uptake of S e 75 Methionine after Intra-Amniotic Injection in Rabbits....Pages 302-303
Exogenous Progesterone and Feto-Placental Function....Pages 304-312
Human Placental Lactogen Production in Vitro 1. Dynamic Studies on Normal-Term Placentas after Stimulation with 17- β -Oestradiol....Pages 313-314
Daily Urinary Hormonal Pattern Following 17 ß-Oestradiol Treatment of Prolonged Pregnancies....Pages 315-317
Experiences with Administration of Dehydroepiandrosterone-Sulfate and Pregnenolone in Cases of Feto-Placental Insufficiency....Pages 318-329
Variation in Maternal Urinary Excretion of Total Oestrogens Following ACTH Administration to the Fetus in Utero....Pages 330-335
A Study of Feto-Neonatal Effects of Maternal Administration of Dehydroepiandrosterone Sulphate (DEAS) in Rats....Pages 336-338
Variation in Maternal Urinary Excretion of Total Oestrogens Following Intra-Amniotic Administration of Dehydroepiandrosterone....Pages 339-342
Levels of Serum Unconjugated Oestrogens after DHEA-S Loading Tests in Human Pregnancy....Pages 343-345
The Reliability of a Placental Function Test Using Dihydroepiandrosterone Sulphate (DHEA-S)....Pages 346-348
21- and 18-C Urinary Steroids after the Oral Administration of DHA-S in Pregnancy....Pages 349-350
Back Matter....Pages 351-356